Clinical Trial Update: 10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of ZD4054 (Zibotentan) in elderly Chinese men with advanced solid tumors has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Zibotentan (zibotentan)

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Solid Malignancies | Phase 1 | Status: COMPLETED